K. Scott Moorefield

K. Scott Moorefield has a diverse work experience spanning over various roles and companies. K. Scott currently holds the position of COO/CBO at Alterome Therapeutics, Inc. Prior to this, they worked as the Senior Vice President of Business Development at Silverback Therapeutics, where they contributed to the company's growth from 2020 to 2022.

In 2019, Moorefield joined Boundless Bio as the Chief Business Officer, where they played a vital role in building the company from scratch. Their responsibilities included leading day-to-day operations, business development, corporate strategy, budgeting, and financial planning. K. Scott also secured foundational IP portfolio licenses from the University of California San Diego and negotiated the lease for the company's headquarters.

Moorefield's previous experience includes working as a Global Business Development Director at Roche from 2014 to 2019 and as a Development Project Team Leader at Genentech in 2015. K. Scott also held various roles at Genentech, including Tarceva Marketing, Strategy and Key Customers, and BioOncology Pipeline Market Planning from 2010 to 2014.

Before joining the industry, Moorefield worked as a Consulting Engagement Manager at Campbell Alliance from 2008 to 2010. K. Scott started their career as a Postdoctoral Scholar at UCSF in 2005 and as a Cancer Research Training Fellow at the National Cancer Institute in 2003.

Overall, Moorefield's work experience showcases their expertise in business development, corporate strategy, operations, and project management in the biotechnology and pharmaceutical industry.

K. Scott Moorefield has an extensive education background. In 1992, they started their educational journey at the University of North Carolina at Chapel Hill, where they pursued a BS/BA degree majoring in Biology/Chemistry. K. Scott successfully completed their undergraduate studies in 1996. Continuing their academic endeavors, they then enrolled at North Carolina State University in 1999 and obtained a PhD in Molecular Oncology and Genomic Sciences in 2005.

Dr. Moorefield's education did not stop there. From 2005 to 2008, they delved into the field of Neurosurgery through a Postdoctorate program at the University of California, San Francisco. This advanced degree would have significantly increased their expertise in the neurosurgical field. In 2018, they attended the University of Chicago Booth School of Business Executive Education, specializing in Negotiations. Although the specific degree they received is not mentioned, this program would have provided valuable insights and skills in negotiation.

Overall, Dr. Moorefield's educational background includes a BS/BA degree in Biology/Chemistry from the University of North Carolina at Chapel Hill, a PhD in Molecular Oncology and Genomic Sciences from North Carolina State University, a Postdoctorate in Neurosurgery from the University of California, San Francisco, and additional executive education in Negotiations from the University of Chicago Booth School of Business.